Figure 3From: Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug Simulated (red) and observed (black) concentration-time profiles of plasma oseltamivir (A), plasma oseltamivir carboxylate (B), and dialysate oseltamivir carboxylate (C) concentrations. OC, oseltamivir carboxylate.Back to article page